Pharsight

Drugs that contain Imiglucerase

1. Cerezyme patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5549892 GENZYME Enhanced in vivo uptake of glucocerebrosidase
Aug, 2013

(10 years ago)

Market Authorisation Date: 23 May, 1994

Treatment: Method of treating a human subject having gaucher's disease

Dosage: INJECTABLE;INJECTION

More Information on Dosage

CEREZYME family patents

Family Patents